Being able to induce both differentiation and apoptosis, and targeting a non-mutation-restricted metabolic pathway, DHODH inhibitors could represent the perfect drugs to obtain synergic treatments in AML, so we started to investigate new combinations. This evidence concerns the gene DHODH and acute myeloid leukemia.